Background {#s1}
==========

Lynch syndrome is an autosomal dominant condition caused by many mismatch repair genes including four important genes; MLH1, PMS2, MSH2 and MSH6 [@R01]. LS was named in honor of Henry T. Lynch, who reported several families in detail during 1966-67 [@R02], [@R03]. LS accounts for 1-5% of all CRC and also present an increased risk of many extra colonic cancer types [@R04]. Mutations in the MMR genes lead to the inactivation or lower efficiency to repair mismatches in DNA that leads to the accumulation of spontaneous mutations mostly consist of the insertions and deletions in short repetitive DNA sequences termed microsatellites. The changes in short microsatellite sequences lead to the microsatellite instability, that is found in the majority of LS tumors (\>90%) in patients with germ line mutations in MMR genes [@R05]. Therefore the current strategy before sequencing these MMR genes is to do the microsatellite instability (MSI) testing. So, if the patient tumor DNA is found with MSI, it will likely yield a mutation in MMR genes. Generally, the five different regions with microsatellites are looked at, and the tumor is considered highly unstable if instability is found in two or more regions. While the tumor is called as unstable-low if the instability is found in only one region and stable if no instability is found [@R06]-[@R09]. The identification of the MMR gene status is very important for surveillance and early intervention especially in the carriers and the family members of the CRC patients, therefore appropriate measure could be taken to limit the disease and improve the survival of the patients and carriers of the disease. And also excluding the family members for any mismatch gene mutation carriers may reduce the worry and high-risk surveillance burden of prevention testing. In this article, we have utilized open target platform for genetic association studies of different genes spectrum involved in LS, their upstream regulators and canonical pathways

Methodology {#s2}
===========

Data-Mining of Genetic Associations in Lynch Syndrome: {#s2a}
------------------------------------------------------

We have used the Open Targets Platform (https://www.targetvalidation.org/),a free-online integrated web resource of genetics, omics and chemical data to aid systematic drug target identification and ranking linking these associations back to the underlying evidence and its source which gives the prioritization of drugs for gene targets based on the strength of their association with a disease such as LS [@R10], [@R11]. The open targets platform assemble data types from multiple open sources and implement a scoring system on the gene target-disease associations aiming at providing users to classify, recognize, and prioritize suitable drug targets for further examination. The Open Targets score for the associations is a range between 0 (no association) and 1(strong association). The Open Targets Platform gives scores with varying shades of blue (the darker the blue, the stronger the genetic association with a particular disease) and the overall association score is the result of the combination of all data source scores [@R10],[@R11].

Ingenuity Pathway Analysis: {#s2b}
---------------------------

The Knowledgebase in Ingenuity Pathway Analysis (IPA) software (Qiagen, USA) was used to obtain the list of genes implicated in the LS. The canonical pathways, upstream regulators, and the differential regulation of gene networks in the LS were further deduced by applying the Fisher\'s Exact Test (P\<0.05) in IPA. The - log P values were plotted in the x-axis and the differentially expressed canonical pathways in the y-axis to derive top canonical pathways implicated in the LS.

Results {#s3}
=======

The results of the study are summarized in [Table 1](#T2){ref-type="table"} and [Table 2](#T2){ref-type="table"} and [Figure 1](#F1){ref-type="fig"} to [Figure 3](#F3){ref-type="fig"}. The most genes associated with LS were found to be the MLH1, MSH2, MSH6, PMS2, EPCAM, TGFBR2, MLH3, FBXO11, and PRSS58. The most of the mutations were reported in MLH1 gene (n= 731, 589pathogenic,and 142likely pathogenic), followed by MSH2 (n=653, 546 pathogenic and 107 likely pathogenic); MSH6 (n=414, 367 pathogenic and 47 likely pathogenic); PMS2 (n=185, 144 pathogenic and 41 likely pathogenic); EPCAM (n=10, 8 pathogenic and 2 likely pathogenic); PRSS58 (n=7, 4 pathogenic and 3 likely pathogenic); MLH3 (n=3, 2 pathogenic and 1 likely pathogenic) and TGFBR2 (one pathogenic only).

Discussion {#s4}
==========

Lynch syndrome is the most common hereditary CRC that account for more than 3% of all the colon cancer cases [@R12]. The genetic heterogeneity of this syndrome is related to the mutations in different genes especially in four mismatch repair genes; MLH1, MSH2, MSH6, and PMS2. The mismatch repair genes contributeto various cellular functions including repairing double-stranded DNA breaks, repairing or errors during DNA synthesis, antirecombination and destabilization of DNA and apoptosis. MMR proteins serve the job of maintenance of genetic material thereforevital for the regulation of the cellular cycle. When the MMR protein is defective or lost altogether, it decreases apoptosis and increases cell survival. This leads to the selective growth advantage to the cells that lead to the more susceptibility to tissue-specific cancers [@R12].

The mutations in MLH1 are mostly present in the LS cases (around 50% of families), while the rest MMR genes mutations account for 40-50% of the syndrome. Different approaches have been utilized so far to detect mutations underlying this syndrome specifically in these four MMR genes (MLH1, MSH2, MSH6 and PMS2), which includes Next-GenerationSequencing based targeted sequencing, Multiplex Ligation-dependent Probe Amplification, Sanger Sequencing and array-CGH [@R13]-[@R15]. In our research, we have utilized Open Targets Platform (https://www.targetvalidation.org/) that allowed the prioritization of the genes based on the strength of their association with LS. The most important genes for the hereditary LS cancer were found to be the MLH1, MSH2, and MSH6. Together they account for more than 90% of the mutations in LS. MLH1 was on top with 731 mutations (589 pathogenic and 142 likely pathogenic), followed by MSH2 with 653 mutations (546 pathogenic and 107 likely pathogenic) and MSH6 with 414 mutations (367 pathogenic and 47 likely pathogenic). While the rest other genes including PMS2, MLH3, EPCAM, PRSS58 and TGFBR2 accounted for less than 10% of total mutations underlying LS. Canonical pathways in LSalso confirmed MMR involvement in syndrome, while other pathways included colorectal cancer metastasis signaling and ovarian cancer signaling ([Figure 2](#F2){ref-type="fig"}).While the analysis of upstream regulators of the target molecules yield to be the MBD4, PTTG1, CHI3L1, TP53,and MYC ([Table 2](#T2){ref-type="table"} shows complete list).

Conclusion {#s5}
==========

The current study has highlighted the mutation spectrum of different genes involved in Lynch syndrome and their association with different upstream regulators and involvement in canonical pathways. This study will further pave the way to accumulate all the data and genetic studies together for better prognostic and treatment options.
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###### Genetic associations observed in Lynch Syndrome

  Gene Symbol   Gene Target ID    Overall Score   Genetic Association Score   Somatic Mutation Score   Gene Name
  ------------- ----------------- --------------- --------------------------- ------------------------ --------------------------------------------------
  MLH1          ENSG00000076242   1               1                           0                        mutL homolog 1
  MSH2          ENSG00000095002   1               1                           0                        mutS homolog 2
  MSH6          ENSG00000116062   1               1                           0                        mutS homolog 6
  PMS2          ENSG00000122512   1               1                           0                        PMS1 homolog 2, mismatch repair system component
  EPCAM         ENSG00000119888   1               1                           0                        epithelial cell adhesion molecule
  TGFBR2        ENSG00000163513   1               1                           0.694444445              transforming growth factor beta receptor 2
  MLH3          ENSG00000119684   1               1                           0                        mutL homolog 3
  FBXO11        ENSG00000138081   0.834652        0.83125                     0                        F-box protein 11
  PRSS58        ENSG00000258223   0.498263889     0.498263889                 0                        serine protease 58

###### Upstream regulators and the corresponding target genes observed in Lynch syndrome

  S. No   Upstream Regulator                             Molecule Type             p-value of overlap   Target Genes
  ------- ---------------------------------------------- ------------------------- -------------------- --------------------------------------------
  1       MBD4                                           enzyme                    3.23E-13             MLH1,MSH2,MSH6,PMS2
  2       PTTG1                                          transcription regulator   2.11E-12             MLH1,MLH3,PMS1,PMS2,Vegf,VEGFA
  3       CHI3L1                                         enzyme                    0.000000379          TGFBR2,Vegf,VEGFA
  4       TP53                                           transcription regulator   0.000000596          MLH1,MSH2,MSH6,PMS2,TGFBR2,TYMS,Vegf,VEGFA
  5       MYC                                            transcription regulator   0.000000924          CD274,EPCAM,MSH2,TGFBR2,TYMS,Vegf,VEGFA
  6       FBLN2                                          other                     0.00000182           Vegf, VEGFA
  7       CCNA1                                          other                     0.00000182           Vegf, VEGFA
  8       IL18                                           cytokine                  0.00000231           MSH2, TGFBR2,Vegf,VEGFA
  9       SRSF6                                          other                     0.00000303           Vegf, VEGFA
  10      PDGFD                                          growth factor             0.00000454           Vegf, VEGFA
  11      SP3                                            transcription regulator   0.00000533           MSH6,TGFBR2,Vegf,VEGFA
  12      E2F1                                           transcription regulator   0.00000539           MLH1,MSH2,TYMS,Vegf,VEGFA
  13      EGLN1                                          enzyme                    0.00000599           TGFBR2,Vegf,VEGFA
  14      KRAS                                           enzyme                    0.00000666           CD274,EPCAM,TGFBR2,Vegf,VEGFA
  15      F3                                             Trans membrane receptor   0.0000072            TGFBR2,Vegf,VEGFA
  16      Cpla2                                          group                     0.00000846           Vegf, VEGFA
  17      IL17A                                          cytokine                  0.0000085            CD274,TGFBR2,Vegf,VEGFA
  18      SP1                                            transcription regulator   0.0000101            MSH6,TGFBR2,TYMS,Vegf,VEGFA
  19      MLH1                                           enzyme                    0.0000109            MLH1,PMS2
  20      IL18BP                                         other                     0.0000109            Vegf, VEGFA
  21      LDL                                            complex                   0.0000129            MLH1,TGFBR2,Vegf,VEGFA
  22      CYP4F2                                         enzyme                    0.0000136            Vegf, VEGFA
  23      HOXB7                                          transcription regulator   0.0000136            Vegf, VEGFA
  24      S100A7                                         other                     0.0000166            Vegf, VEGFA
  25      NFkB (complex)                                 complex                   0.0000184            CD274,EPCAM,MSH2,Vegf,VEGFA
  26      miR-150-5p (and other miRNAs w/seed CUCCCAA)   mature micro RNA          0.0000199            Vegf, VEGFA
  27      SERPINB5                                       other                     0.0000235            Vegf, VEGFA
  28      HHEX                                           transcription regulator   0.0000275            Vegf, VEGFA
  29      mir-155                                        Micro RNA                 0.000029             MLH1,MSH2,MSH6
  30      MET                                            kinase                    0.0000314            CD274,Vegf,VEGFA
  31      NREP                                           other                     0.0000317            TGFBR2,VEGFA
  32      RLN2                                           other                     0.0000317            Vegf, VEGFA
  33      PI3K (family)                                  group                     0.0000323            CD274,Vegf,VEGFA
  34      CBX4                                           transcription regulator   0.0000362            MSH2,VEGFA
  35      APEX1                                          enzyme                    0.000041             Vegf, VEGFA
  36      ALOX12                                         enzyme                    0.0000461            TGFBR2,VEGFA
  37      PAEP                                           other                     0.0000461            CD274,VEGFA
  38      Angio tensin II receptor type 1                group                     0.0000515            Vegf,VEGFA
  39      HMOX1                                          enzyme                    0.0000515            CD274,Vegf,VEGFA
  40      TP73                                           transcription regulator   0.0000516            MLH1,MUTYH,Vegf,VEGFA
  41      FOXM1                                          transcription regulator   0.0000576            TGFBR2,Vegf,VEGFA
  42      RAS                                            group                     0.0000602            CD274,Vegf,VEGFA
  43      VHL                                            transcription regulator   0.0000602            TYMS, Vegf, VEGFA
  44      SMAD7                                          transcription regulator   0.0000615            TGFBR2,Vegf,VEGFA
  45      Histone h4                                     group                     0.0000741            MSH2,TGFBR2,TYMS
  46      HTATIP2                                        transcription regulator   0.0000761            Vegf, VEGFA
  47      RELA                                           transcription regulator   0.0000808            CD274,EPCAM,Vegf,VEGFA
  48      IL15                                           cytokine                  0.0000837            CD274,TGFBR2,Vegf,VEGFA
  49      IL4                                            cytokine                  0.0000952            CD274,MSH2,TGFBR2,Vegf,VEGFA
  50      miR-155-5p (miRNAs w/seed UAAUGCU)             mature micro RNA          0.0000969            MLH1,MSH2,MSH6
  51      JUN                                            transcription regulator   0.000104             CD274,MSH2,Vegf,VEGFA
  52      CTSB                                           peptidase                 0.000105             Vegf, VEGFA
  53      SP4                                            transcription regulator   0.000114             Vegf, VEGFA
  54      PTEN                                           phosphatase               0.000123             CD274,TGFBR2,Vegf,VEGFA
  55      BRCA1                                          transcription regulator   0.000128             MLH1,Vegf,VEGFA
  56      IGF2                                           growth factor             0.000135             PMS1,Vegf,VEGFA
  57      NOX4                                           enzyme                    0.00014              Vegf, VEGFA
  58      MAP2K1                                         kinase                    0.000148             CD274,Vegf,VEGFA
  59      GNAI2                                          enzyme                    0.000149             MLH1,PMS2
  60      STK11                                          kinase                    0.000151             CD274,Vegf,VEGFA
  61      HGF                                            growth factor             0.000156             EPCAM,TGFBR2,Vegf,VEGFA
  62      THBS1                                          other                     0.000158             Vegf, VEGFA
  63      DRD2                                           GPCR                      0.000168             TGFBR2,VEGFA
  64      PAK1                                           kinase                    0.000168             Vegf, VEGFA
  65      SPP1                                           cytokine                  0.000178             TGFBR2,Vegf,VEGFA
  66      TEAD4                                          transcription regulator   0.000178             Vegf, VEGFA
  67      miR-16-5p (and other miRNAs w/seed AGCAGCA)    mature micro RNA          0.000192             MSH2,PMS1,VEGFA
  68      TGFBR2                                         kinase                    0.000197             TGFBR2,Vegf,VEGFA
  69      SFRP1                                          Trans membrane receptor   0.000199             EPCAM, Vegf
  70      MERTK                                          kinase                    0.000233             CD274,Vegf
  71      ETS1                                           transcription regulator   0.000236             TGFBR2,TYMS,VEGFA
  72      Jnk                                            group                     0.000249             MSH2,TGFBR2,Vegf
  73      STUB1                                          enzyme                    0.000257             Vegf, VEGFA
  74      TGFB1                                          growth factor             0.000265             EPCAM,MSH6,TGFBR2,TYMS,Vegf,VEGFA
  75      ANGPT1                                         growth factor             0.00027              Vegf,VEGFA
  76      Hsp27                                          group                     0.000283             CD274,Vegf
  77      HBEGF                                          growth factor             0.000283             Vegf, VEGFA
  78      TNF                                            cytokine                  0.000296             CD274,EPCAM,MSH2,TGFBR2,Vegf,VEGFA
  79      C3AR1                                          GPCR                      0.000323             TGFBR2,Vegf
  80      BSG                                            transporter               0.000323             Vegf, VEGFA
  81      ITGB2                                          Trans membrane receptor   0.000351             TGFBR2,VEGFA
  82      MAPK7                                          kinase                    0.000351             Vegf,VEGFA
  83      NOTCH1                                         transcription regulator   0.000373             TGFBR2, Vegf,VEGFA
  84      KLF4                                           transcription regulator   0.000377             EPCAM, Vegf, VEGFA
  85      EPHB4                                          kinase                    0.00038              TGFBR2,Vegf
  86      OLR1                                           Trans membrane receptor   0.00038              TGFBR2,Vegf
  87      mir-21                                         Micro RNA                 0.000395             CD274,MSH2,Vegf
  88      ALB                                            transporter               0.000395             Vegf, VEGFA
  89      HDAC1                                          transcription regulator   0.000408             TGFBR2,TYMS,Vegf
  90      DCN                                            other                     0.000426             Vegf, VEGFA

![Top gene targets linked with the Lynch Syndrome was obtained from the Open Targets Platform based on the genetic association score (Darker the blue more the genetic association with Lynch Syndrome).](97320630015269F1){#F1}

![Canonical Pathways in Lynch Syndrome.The canonical pathways, in the Lynch syndrome, were identified using the IPA. The - log P values were plotted in the x-axis and the differentially expressed canonical pathways in the y-axis to derive top canonical pathways such as mismatch repair signaling implicated in the Lynch Syndrome.](97320630015269F2){#F2}

![The pathogenic genetic variants in observed in MLH1, MSH2, MSH6, PMS2, MLH3, EPCAM, and TGFBR2 genes associated with Lynch syndrome are shown in the genome browser.](97320630015269F3){#F3}
